EBSCO Logo
Connecting you to content on EBSCOhost
Results
Title

Protease-activated receptor-2 ligands reveal orthosteric and allosteric mechanisms of receptor inhibition.

Authors

Kennedy, Amanda J.; Sundström, Linda; Geschwindner, Stefan; Poon, Eunice K. Y.; Jiang, Yuhong; Chen, Rongfeng; Cooke, Rob; Johnstone, Shawn; Madin, Andrew; Lim, Junxian; Liu, Qingqi; Lohman, Rink-Jan; Nordqvist, Anneli; Fridén-Saxin, Maria; Yang, Wenzhen; Brown, Dean G.; Fairlie, David P.; Dekker, Niek

Abstract

Protease-activated receptor-2 (PAR2) has been implicated in multiple pathophysiologies but drug discovery is challenging due to low small molecule tractability and a complex activation mechanism. Here we report the pharmacological profiling of a potent new agonist, suggested by molecular modelling to bind in the putative orthosteric site, and two novel PAR2 antagonists with distinctly different mechanisms of inhibition. We identify coupling between different PAR2 binding sites. One antagonist is a competitive inhibitor that binds to the orthosteric site, while a second antagonist is a negative allosteric modulator that binds at a remote site. The allosteric modulator shows probe dependence, more effectively inhibiting peptide than protease activation of PAR2 signalling. Importantly, both antagonists are active in vivo, inhibiting PAR2 agonist-induced acute paw inflammation in rats and preventing activation of mast cells and neutrophils. These results highlight two distinct mechanisms of inhibition that potentially could be targeted for future development of drugs that modulate PAR2. Kennedy et al. report the pharmacological and in vivo profiling of two small molecule PAR2 inhibitors and an agonist. They conclude that while the small molecule agonist and one of the inhibitors bind to the orthosteric PAR2 binding site, the other inhibitor is a negative allosteric modulator, highlighting two distinct mechanisms of inhibition that could be targeted for future development of drugs that modulate PAR2.

Subjects

PROTEASE-activated receptors; LIGANDS (Biochemistry); PATHOLOGICAL physiology; MAST cells; IMMUNOMODULATORS

Publication

Communications Biology, 2020, Vol 3, Issue 1, p1

ISSN

2399-3642

Publication type

Academic Journal

DOI

10.1038/s42003-020-01504-0

EBSCO Connect | Privacy policy | Terms of use | Copyright | Manage my cookies
Journals | Subjects | Sitemap
© 2025 EBSCO Industries, Inc. All rights reserved